Suchergebnisse - "Wargny, Matthieu"

PubPharm (5)

1

'Comparative outcomes of cefazolin versus anti-staphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis : a post-hoc analysis multicentre French cohort study'-author's reply

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Lecomte, R. | Deschanvres, C. | Coudol, S. | +3

CommentOn: Clin Microbiol Infect. 2021 Aug;27(8):1179. - PMID 33581355

2

Glucose-lowering treatments and COVID-19 mortality in T2DM

enthalten in: Nature reviews. Endocrinology | 2021

von Hadjadj, S. | Wargny, M.

CommentOn: Lancet Diabetes Endocrinol. 2021 May;9(5):293-303. - PMID 33798464

3

Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter

enthalten in: Diabetologia | 2020

von Cariou, B. | Hadjadj, S. | Wargny, M. | +38

CommentOn: Diabetologia. 2020 Nov;63(11):2486-2487. - PMID 32632527

4

Type 1 Diabetes in People Hospitalized for COVID-19 : New Insights From the CORONADO Study

enthalten in: Diabetes care | 2020

von Wargny, M. | Gourdy, P. | Ludwig, L. | +111

CommentOn: Diabetologia. 2020 Aug;63(8):1500-1515. - PMID 32472191

5

Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399-1407

enthalten in: Diabetes care | 2020

von Cariou, B. | Hadjadj, S. | Wargny, M. | +2

CommentOn: Diabetes Care. 2020 Jul;43(7):1399-1407. - PMID 32409498

1
[1]